COVID : Hetero enters into voluntary licensing agreement with MSD for manufacturing of ‘Molnupiravir’
Hyderabad, April 27 : Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, on Tuesday announced that it has entered into a non-exclusive voluntary licensing agreement with MSD…